nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—KCNQ4—ear—melanoma	0.0493	0.352	CbGeAlD
Ezogabine—Nail discolouration—Docetaxel—melanoma	0.0213	0.0563	CcSEcCtD
Ezogabine—Dysphasia—Temozolomide—melanoma	0.0184	0.0486	CcSEcCtD
Ezogabine—KCNQ4—eye—melanoma	0.013	0.0926	CbGeAlD
Ezogabine—KCNQ4—retina—melanoma	0.0129	0.0917	CbGeAlD
Ezogabine—KCNQ5—eye—melanoma	0.0126	0.09	CbGeAlD
Ezogabine—KCNQ5—retina—melanoma	0.0125	0.0892	CbGeAlD
Ezogabine—Raised liver function tests—Dactinomycin—melanoma	0.00963	0.0254	CcSEcCtD
Ezogabine—KCNQ2—eye—melanoma	0.00932	0.0665	CbGeAlD
Ezogabine—KCNQ4—head—melanoma	0.00737	0.0525	CbGeAlD
Ezogabine—KCNQ5—head—melanoma	0.00717	0.0511	CbGeAlD
Ezogabine—Encephalopathy—Carmustine—melanoma	0.00648	0.0171	CcSEcCtD
Ezogabine—Aphasia—Carmustine—melanoma	0.00642	0.0169	CcSEcCtD
Ezogabine—Aphasia—Temozolomide—melanoma	0.0062	0.0164	CcSEcCtD
Ezogabine—Hypokinesia—Carmustine—melanoma	0.00616	0.0163	CcSEcCtD
Ezogabine—Raised liver function tests—Docetaxel—melanoma	0.00579	0.0153	CcSEcCtD
Ezogabine—KCNQ3—head—melanoma	0.00575	0.041	CbGeAlD
Ezogabine—KCNQ2—head—melanoma	0.00529	0.0377	CbGeAlD
Ezogabine—Memory impairment—Temozolomide—melanoma	0.00512	0.0135	CcSEcCtD
Ezogabine—KCNQ5—lymph node—melanoma	0.00502	0.0358	CbGeAlD
Ezogabine—Disturbance in attention—Temozolomide—melanoma	0.00464	0.0122	CcSEcCtD
Ezogabine—Infestation NOS—Vemurafenib—melanoma	0.0044	0.0116	CcSEcCtD
Ezogabine—Infestation—Vemurafenib—melanoma	0.0044	0.0116	CcSEcCtD
Ezogabine—Gait disturbance—Carmustine—melanoma	0.00426	0.0113	CcSEcCtD
Ezogabine—Coordination abnormal—Carmustine—melanoma	0.00424	0.0112	CcSEcCtD
Ezogabine—Gait disturbance—Temozolomide—melanoma	0.00412	0.0109	CcSEcCtD
Ezogabine—Coordination abnormal—Temozolomide—melanoma	0.0041	0.0108	CcSEcCtD
Ezogabine—Oedema peripheral—Vemurafenib—melanoma	0.00389	0.0103	CcSEcCtD
Ezogabine—Disorientation—Bleomycin—melanoma	0.00387	0.0102	CcSEcCtD
Ezogabine—Coma—Carmustine—melanoma	0.0038	0.01	CcSEcCtD
Ezogabine—Eye disorder—Vemurafenib—melanoma	0.00369	0.00974	CcSEcCtD
Ezogabine—Alopecia—Vemurafenib—melanoma	0.00349	0.00921	CcSEcCtD
Ezogabine—Malnutrition—Vemurafenib—melanoma	0.00344	0.00908	CcSEcCtD
Ezogabine—Amnesia—Carmustine—melanoma	0.00322	0.00848	CcSEcCtD
Ezogabine—Amnesia—Temozolomide—melanoma	0.00311	0.0082	CcSEcCtD
Ezogabine—Diplopia—Carmustine—melanoma	0.00302	0.00797	CcSEcCtD
Ezogabine—Liver function test abnormal—Dactinomycin—melanoma	0.00298	0.00786	CcSEcCtD
Ezogabine—Diplopia—Temozolomide—melanoma	0.00292	0.0077	CcSEcCtD
Ezogabine—Dysphagia—Dactinomycin—melanoma	0.00279	0.00736	CcSEcCtD
Ezogabine—Infection—Vemurafenib—melanoma	0.00279	0.00736	CcSEcCtD
Ezogabine—Liver function test abnormal—Carmustine—melanoma	0.00279	0.00736	CcSEcCtD
Ezogabine—Nervous system disorder—Vemurafenib—melanoma	0.00275	0.00726	CcSEcCtD
Ezogabine—Dysphagia—Carmustine—melanoma	0.00261	0.00689	CcSEcCtD
Ezogabine—Neutropenia—Dactinomycin—melanoma	0.00261	0.00688	CcSEcCtD
Ezogabine—Haematuria—Bleomycin—melanoma	0.00254	0.00671	CcSEcCtD
Ezogabine—Dysphagia—Temozolomide—melanoma	0.00252	0.00666	CcSEcCtD
Ezogabine—Neutropenia—Carmustine—melanoma	0.00244	0.00644	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00242	0.0064	CcSEcCtD
Ezogabine—Fatigue—Vemurafenib—melanoma	0.00242	0.00639	CcSEcCtD
Ezogabine—Constipation—Vemurafenib—melanoma	0.0024	0.00633	CcSEcCtD
Ezogabine—Neutropenia—Temozolomide—melanoma	0.00236	0.00623	CcSEcCtD
Ezogabine—Dysuria—Temozolomide—melanoma	0.00236	0.00623	CcSEcCtD
Ezogabine—Weight increased—Temozolomide—melanoma	0.0023	0.00606	CcSEcCtD
Ezogabine—Infestation NOS—Temozolomide—melanoma	0.00225	0.00594	CcSEcCtD
Ezogabine—Infestation—Temozolomide—melanoma	0.00225	0.00594	CcSEcCtD
Ezogabine—Hepatobiliary disease—Temozolomide—melanoma	0.00213	0.00561	CcSEcCtD
Ezogabine—Alopecia—Bleomycin—melanoma	0.00212	0.00558	CcSEcCtD
Ezogabine—Hallucination—Carmustine—melanoma	0.00208	0.00549	CcSEcCtD
Ezogabine—Oedema peripheral—Carmustine—melanoma	0.00206	0.00543	CcSEcCtD
Ezogabine—Asthenia—Vemurafenib—melanoma	0.00201	0.00531	CcSEcCtD
Ezogabine—Visual impairment—Carmustine—melanoma	0.00201	0.00531	CcSEcCtD
Ezogabine—Hallucination—Temozolomide—melanoma	0.00201	0.0053	CcSEcCtD
Ezogabine—Urinary tract disorder—Temozolomide—melanoma	0.00199	0.00526	CcSEcCtD
Ezogabine—Oedema peripheral—Temozolomide—melanoma	0.00199	0.00525	CcSEcCtD
Ezogabine—Urethral disorder—Temozolomide—melanoma	0.00198	0.00522	CcSEcCtD
Ezogabine—Alopecia—Dactinomycin—melanoma	0.00197	0.00521	CcSEcCtD
Ezogabine—Eye disorder—Carmustine—melanoma	0.00195	0.00515	CcSEcCtD
Ezogabine—Visual impairment—Temozolomide—melanoma	0.00195	0.00514	CcSEcCtD
Ezogabine—Ill-defined disorder—Bleomycin—melanoma	0.00193	0.0051	CcSEcCtD
Ezogabine—Eye disorder—Temozolomide—melanoma	0.00189	0.00498	CcSEcCtD
Ezogabine—Malaise—Bleomycin—melanoma	0.00188	0.00496	CcSEcCtD
Ezogabine—Leukopenia—Bleomycin—melanoma	0.00187	0.00492	CcSEcCtD
Ezogabine—Dizziness—Vemurafenib—melanoma	0.00186	0.0049	CcSEcCtD
Ezogabine—Alopecia—Carmustine—melanoma	0.00185	0.00487	CcSEcCtD
Ezogabine—Mental disorder—Carmustine—melanoma	0.00183	0.00483	CcSEcCtD
Ezogabine—Malnutrition—Carmustine—melanoma	0.00182	0.0048	CcSEcCtD
Ezogabine—Ill-defined disorder—Dactinomycin—melanoma	0.0018	0.00476	CcSEcCtD
Ezogabine—Liver function test abnormal—Docetaxel—melanoma	0.00179	0.00473	CcSEcCtD
Ezogabine—Alopecia—Temozolomide—melanoma	0.00178	0.00471	CcSEcCtD
Ezogabine—Rash—Vemurafenib—melanoma	0.00177	0.00467	CcSEcCtD
Ezogabine—Mental disorder—Temozolomide—melanoma	0.00177	0.00467	CcSEcCtD
Ezogabine—Dermatitis—Vemurafenib—melanoma	0.00177	0.00467	CcSEcCtD
Ezogabine—Malnutrition—Temozolomide—melanoma	0.00176	0.00464	CcSEcCtD
Ezogabine—Discomfort—Bleomycin—melanoma	0.00175	0.00463	CcSEcCtD
Ezogabine—Malaise—Dactinomycin—melanoma	0.00175	0.00463	CcSEcCtD
Ezogabine—Leukopenia—Dactinomycin—melanoma	0.00174	0.00459	CcSEcCtD
Ezogabine—Confusional state—Bleomycin—melanoma	0.00172	0.00453	CcSEcCtD
Ezogabine—Vision blurred—Carmustine—melanoma	0.00171	0.00452	CcSEcCtD
Ezogabine—Tremor—Carmustine—melanoma	0.0017	0.0045	CcSEcCtD
Ezogabine—Infection—Bleomycin—melanoma	0.00169	0.00446	CcSEcCtD
Ezogabine—Dysphagia—Docetaxel—melanoma	0.00168	0.00443	CcSEcCtD
Ezogabine—Nausea—Vemurafenib—melanoma	0.00167	0.0044	CcSEcCtD
Ezogabine—Thrombocytopenia—Bleomycin—melanoma	0.00167	0.00439	CcSEcCtD
Ezogabine—Vision blurred—Temozolomide—melanoma	0.00166	0.00437	CcSEcCtD
Ezogabine—Tremor—Temozolomide—melanoma	0.00165	0.00435	CcSEcCtD
Ezogabine—Discomfort—Dactinomycin—melanoma	0.00163	0.00431	CcSEcCtD
Ezogabine—Ill-defined disorder—Temozolomide—melanoma	0.00163	0.0043	CcSEcCtD
Ezogabine—Leukopenia—Carmustine—melanoma	0.00163	0.0043	CcSEcCtD
Ezogabine—Malaise—Temozolomide—melanoma	0.00159	0.00418	CcSEcCtD
Ezogabine—Vertigo—Temozolomide—melanoma	0.00158	0.00417	CcSEcCtD
Ezogabine—Infection—Dactinomycin—melanoma	0.00158	0.00416	CcSEcCtD
Ezogabine—Leukopenia—Temozolomide—melanoma	0.00157	0.00415	CcSEcCtD
Ezogabine—Neutropenia—Docetaxel—melanoma	0.00157	0.00414	CcSEcCtD
Ezogabine—Thrombocytopenia—Dactinomycin—melanoma	0.00155	0.0041	CcSEcCtD
Ezogabine—Anxiety—Carmustine—melanoma	0.00154	0.00407	CcSEcCtD
Ezogabine—Paraesthesia—Bleomycin—melanoma	0.00153	0.00403	CcSEcCtD
Ezogabine—Weight increased—Docetaxel—melanoma	0.00153	0.00403	CcSEcCtD
Ezogabine—Dyspnoea—Bleomycin—melanoma	0.00152	0.004	CcSEcCtD
Ezogabine—Confusional state—Carmustine—melanoma	0.0015	0.00395	CcSEcCtD
Ezogabine—Infestation NOS—Docetaxel—melanoma	0.0015	0.00395	CcSEcCtD
Ezogabine—Infestation—Docetaxel—melanoma	0.0015	0.00395	CcSEcCtD
Ezogabine—Anxiety—Temozolomide—melanoma	0.00149	0.00394	CcSEcCtD
Ezogabine—Discomfort—Temozolomide—melanoma	0.00148	0.0039	CcSEcCtD
Ezogabine—Infection—Carmustine—melanoma	0.00148	0.00389	CcSEcCtD
Ezogabine—Dry mouth—Temozolomide—melanoma	0.00146	0.00386	CcSEcCtD
Ezogabine—Thrombocytopenia—Carmustine—melanoma	0.00145	0.00384	CcSEcCtD
Ezogabine—Confusional state—Temozolomide—melanoma	0.00145	0.00382	CcSEcCtD
Ezogabine—Infection—Temozolomide—melanoma	0.00143	0.00376	CcSEcCtD
Ezogabine—Hepatobiliary disease—Docetaxel—melanoma	0.00141	0.00373	CcSEcCtD
Ezogabine—Nervous system disorder—Temozolomide—melanoma	0.00141	0.00371	CcSEcCtD
Ezogabine—Thrombocytopenia—Temozolomide—melanoma	0.0014	0.00371	CcSEcCtD
Ezogabine—Feeling abnormal—Bleomycin—melanoma	0.0014	0.0037	CcSEcCtD
Ezogabine—Hyperhidrosis—Temozolomide—melanoma	0.00139	0.00366	CcSEcCtD
Ezogabine—Fatigue—Dactinomycin—melanoma	0.00137	0.00361	CcSEcCtD
Ezogabine—Paraesthesia—Carmustine—melanoma	0.00133	0.00352	CcSEcCtD
Ezogabine—Urinary tract disorder—Docetaxel—melanoma	0.00133	0.0035	CcSEcCtD
Ezogabine—Dyspnoea—Carmustine—melanoma	0.00132	0.00349	CcSEcCtD
Ezogabine—Oedema peripheral—Docetaxel—melanoma	0.00132	0.00349	CcSEcCtD
Ezogabine—Somnolence—Carmustine—melanoma	0.00132	0.00348	CcSEcCtD
Ezogabine—Urethral disorder—Docetaxel—melanoma	0.00132	0.00347	CcSEcCtD
Ezogabine—Feeling abnormal—Dactinomycin—melanoma	0.00131	0.00345	CcSEcCtD
Ezogabine—Visual impairment—Docetaxel—melanoma	0.00129	0.00342	CcSEcCtD
Ezogabine—Paraesthesia—Temozolomide—melanoma	0.00129	0.0034	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Carmustine—melanoma	0.00128	0.00338	CcSEcCtD
Ezogabine—Dyspnoea—Temozolomide—melanoma	0.00128	0.00338	CcSEcCtD
Ezogabine—Somnolence—Temozolomide—melanoma	0.00128	0.00337	CcSEcCtD
Ezogabine—Constipation—Carmustine—melanoma	0.00127	0.00335	CcSEcCtD
Ezogabine—Dyspepsia—Temozolomide—melanoma	0.00126	0.00333	CcSEcCtD
Ezogabine—Eye disorder—Docetaxel—melanoma	0.00126	0.00331	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Temozolomide—melanoma	0.00124	0.00327	CcSEcCtD
Ezogabine—Fatigue—Temozolomide—melanoma	0.00124	0.00326	CcSEcCtD
Ezogabine—Constipation—Temozolomide—melanoma	0.00123	0.00324	CcSEcCtD
Ezogabine—Feeling abnormal—Carmustine—melanoma	0.00122	0.00323	CcSEcCtD
Ezogabine—Asthenia—Bleomycin—melanoma	0.00122	0.00322	CcSEcCtD
Ezogabine—Alopecia—Docetaxel—melanoma	0.00119	0.00313	CcSEcCtD
Ezogabine—Feeling abnormal—Temozolomide—melanoma	0.00118	0.00312	CcSEcCtD
Ezogabine—Mental disorder—Docetaxel—melanoma	0.00118	0.0031	CcSEcCtD
Ezogabine—Malnutrition—Docetaxel—melanoma	0.00117	0.00308	CcSEcCtD
Ezogabine—Asthenia—Dactinomycin—melanoma	0.00114	0.003	CcSEcCtD
Ezogabine—Muscle spasms—Docetaxel—melanoma	0.00112	0.00297	CcSEcCtD
Ezogabine—Rash—Bleomycin—melanoma	0.00107	0.00283	CcSEcCtD
Ezogabine—Dermatitis—Bleomycin—melanoma	0.00107	0.00283	CcSEcCtD
Ezogabine—Asthenia—Carmustine—melanoma	0.00107	0.00281	CcSEcCtD
Ezogabine—Syncope—Docetaxel—melanoma	0.00105	0.00277	CcSEcCtD
Ezogabine—Leukopenia—Docetaxel—melanoma	0.00105	0.00276	CcSEcCtD
Ezogabine—Asthenia—Temozolomide—melanoma	0.00103	0.00272	CcSEcCtD
Ezogabine—Loss of consciousness—Docetaxel—melanoma	0.00103	0.00271	CcSEcCtD
Ezogabine—Nausea—Bleomycin—melanoma	0.00101	0.00267	CcSEcCtD
Ezogabine—Rash—Dactinomycin—melanoma	0.001	0.00264	CcSEcCtD
Ezogabine—Dizziness—Carmustine—melanoma	0.000982	0.00259	CcSEcCtD
Ezogabine—Dry mouth—Docetaxel—melanoma	0.000973	0.00257	CcSEcCtD
Ezogabine—Confusional state—Docetaxel—melanoma	0.000962	0.00254	CcSEcCtD
Ezogabine—Dizziness—Temozolomide—melanoma	0.000949	0.0025	CcSEcCtD
Ezogabine—Infection—Docetaxel—melanoma	0.000948	0.0025	CcSEcCtD
Ezogabine—Nausea—Dactinomycin—melanoma	0.000942	0.00249	CcSEcCtD
Ezogabine—Shock—Docetaxel—melanoma	0.000939	0.00248	CcSEcCtD
Ezogabine—Rash—Carmustine—melanoma	0.000936	0.00247	CcSEcCtD
Ezogabine—Nervous system disorder—Docetaxel—melanoma	0.000936	0.00247	CcSEcCtD
Ezogabine—Dermatitis—Carmustine—melanoma	0.000935	0.00247	CcSEcCtD
Ezogabine—Thrombocytopenia—Docetaxel—melanoma	0.000934	0.00247	CcSEcCtD
Ezogabine—Rash—Temozolomide—melanoma	0.000905	0.00239	CcSEcCtD
Ezogabine—Dermatitis—Temozolomide—melanoma	0.000904	0.00238	CcSEcCtD
Ezogabine—Nausea—Carmustine—melanoma	0.000882	0.00233	CcSEcCtD
Ezogabine—Paraesthesia—Docetaxel—melanoma	0.000857	0.00226	CcSEcCtD
Ezogabine—Nausea—Temozolomide—melanoma	0.000852	0.00225	CcSEcCtD
Ezogabine—Dyspnoea—Docetaxel—melanoma	0.000851	0.00224	CcSEcCtD
Ezogabine—Somnolence—Docetaxel—melanoma	0.000848	0.00224	CcSEcCtD
Ezogabine—Dyspepsia—Docetaxel—melanoma	0.00084	0.00222	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Docetaxel—melanoma	0.000824	0.00217	CcSEcCtD
Ezogabine—Fatigue—Docetaxel—melanoma	0.000823	0.00217	CcSEcCtD
Ezogabine—Constipation—Docetaxel—melanoma	0.000816	0.00215	CcSEcCtD
Ezogabine—Feeling abnormal—Docetaxel—melanoma	0.000786	0.00207	CcSEcCtD
Ezogabine—Asthenia—Docetaxel—melanoma	0.000685	0.00181	CcSEcCtD
Ezogabine—Dizziness—Docetaxel—melanoma	0.000631	0.00166	CcSEcCtD
Ezogabine—Rash—Docetaxel—melanoma	0.000602	0.00159	CcSEcCtD
Ezogabine—Dermatitis—Docetaxel—melanoma	0.000601	0.00159	CcSEcCtD
Ezogabine—Nausea—Docetaxel—melanoma	0.000567	0.0015	CcSEcCtD
Ezogabine—UGT1A9—Metabolism—UGT2B10—melanoma	0.000241	0.000501	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—LUM—melanoma	0.000241	0.000501	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—UGT2B10—melanoma	0.000241	0.000501	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000238	0.000495	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HPSE—melanoma	0.000236	0.000492	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CUBN—melanoma	0.000232	0.000482	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—MAPK1—melanoma	0.000232	0.000482	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—MAPK1—melanoma	0.000232	0.000482	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC6A11—melanoma	0.000231	0.000481	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIP4K2A—melanoma	0.000231	0.000481	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP17A1—melanoma	0.000231	0.00048	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—FGF2—melanoma	0.000229	0.000477	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—FGF2—melanoma	0.000229	0.000477	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—melanoma	0.000228	0.000475	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—melanoma	0.000228	0.000475	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—NRAS—melanoma	0.000226	0.000469	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—NRAS—melanoma	0.000226	0.000469	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—MTAP—melanoma	0.000225	0.000467	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SDHD—melanoma	0.000224	0.000466	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BSG—melanoma	0.000224	0.000466	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CSPG4—melanoma	0.000224	0.000466	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HS3ST5—melanoma	0.000224	0.000466	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HS3ST5—melanoma	0.000224	0.000466	CbGpPWpGaD
Ezogabine—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—melanoma	0.000218	0.000454	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GNA11—melanoma	0.000218	0.000453	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPAM—melanoma	0.000217	0.000451	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK3—melanoma	0.000216	0.000449	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK3—melanoma	0.000216	0.000449	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—FASN—melanoma	0.000213	0.000444	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—ERBB2—melanoma	0.000212	0.00044	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—ERBB2—melanoma	0.000212	0.00044	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC5A5—melanoma	0.00021	0.000436	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—MAPK1—melanoma	0.000206	0.000428	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—MAPK1—melanoma	0.000206	0.000428	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—EGFR—melanoma	0.000206	0.000428	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—EGFR—melanoma	0.000206	0.000428	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ACER3—melanoma	0.000203	0.000422	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GNAQ—melanoma	0.000203	0.000421	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CD44—melanoma	0.000203	0.000421	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—LUM—melanoma	0.0002	0.000417	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PHGDH—melanoma	0.0002	0.000417	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HPSE—melanoma	0.000196	0.000409	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP1B1—melanoma	0.000194	0.000404	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—KRAS—melanoma	0.000194	0.000404	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—KRAS—melanoma	0.000194	0.000404	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CUBN—melanoma	0.000193	0.000401	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SDHD—melanoma	0.000186	0.000387	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CSPG4—melanoma	0.000186	0.000387	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BSG—melanoma	0.000186	0.000387	CbGpPWpGaD
Ezogabine—KCNQ3—Neuronal System—HRAS—melanoma	0.000186	0.000387	CbGpPWpGaD
Ezogabine—KCNQ2—Neuronal System—HRAS—melanoma	0.000186	0.000387	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UGT2B10—melanoma	0.000186	0.000386	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—CTNNB1—melanoma	0.000185	0.000385	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—CTNNB1—melanoma	0.000185	0.000385	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PLA2G6—melanoma	0.000184	0.000384	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP9—melanoma	0.000182	0.000378	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP9—melanoma	0.000182	0.000378	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPAM—melanoma	0.00018	0.000375	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.00018	0.000375	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NFKB1—melanoma	0.00018	0.000374	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NFKB1—melanoma	0.00018	0.000374	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HS3ST5—melanoma	0.000173	0.000359	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLCB4—melanoma	0.00017	0.000353	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLCB4—melanoma	0.00017	0.000353	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000167	0.000347	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—VCAN—melanoma	0.000166	0.000345	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—HRAS—melanoma	0.000165	0.000343	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—HRAS—melanoma	0.000165	0.000343	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—melanoma	0.000163	0.000339	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—melanoma	0.000163	0.000339	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—STAT3—melanoma	0.000161	0.000336	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—STAT3—melanoma	0.000161	0.000336	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—NRAS—melanoma	0.000161	0.000335	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—NRAS—melanoma	0.000161	0.000335	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCB1—melanoma	0.00016	0.000333	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC6A11—melanoma	0.00016	0.000332	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC6A11—melanoma	0.00016	0.000332	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIP4K2A—melanoma	0.00016	0.000332	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIP4K2A—melanoma	0.00016	0.000332	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—IL6—melanoma	0.000158	0.000329	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—IL6—melanoma	0.000158	0.000329	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—MTAP—melanoma	0.000155	0.000323	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—MTAP—melanoma	0.000155	0.000323	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK3—melanoma	0.000154	0.000321	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK3—melanoma	0.000154	0.000321	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLA2G6—melanoma	0.000153	0.000319	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000152	0.000316	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PRKCA—melanoma	0.000147	0.000306	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MAPK1—melanoma	0.000147	0.000305	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MAPK1—melanoma	0.000147	0.000305	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—EGFR—melanoma	0.000147	0.000305	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—EGFR—melanoma	0.000147	0.000305	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ERCC2—melanoma	0.000146	0.000304	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP17A1—melanoma	0.00014	0.000291	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—melanoma	0.00014	0.000291	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—melanoma	0.00014	0.000291	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—KRAS—melanoma	0.000139	0.000288	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—KRAS—melanoma	0.000139	0.000288	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—LUM—melanoma	0.000138	0.000288	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—LUM—melanoma	0.000138	0.000288	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PHGDH—melanoma	0.000138	0.000288	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PHGDH—melanoma	0.000138	0.000288	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—VCAN—melanoma	0.000138	0.000286	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HPSE—melanoma	0.000136	0.000282	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HPSE—melanoma	0.000136	0.000282	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CUBN—melanoma	0.000133	0.000277	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CUBN—melanoma	0.000133	0.000277	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNA11—melanoma	0.000132	0.000275	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLCB4—melanoma	0.000131	0.000272	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—FASN—melanoma	0.000129	0.000269	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BSG—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BSG—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CSPG4—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CSPG4—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SDHD—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SDHD—melanoma	0.000129	0.000268	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC5A5—melanoma	0.000127	0.000264	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPAM—melanoma	0.000125	0.000259	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPAM—melanoma	0.000125	0.000259	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC6A11—melanoma	0.000123	0.000256	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIP4K2A—melanoma	0.000123	0.000256	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GNAQ—melanoma	0.000123	0.000255	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CD44—melanoma	0.000123	0.000255	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—MTAP—melanoma	0.00012	0.000249	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—HRAS—melanoma	0.000118	0.000245	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—HRAS—melanoma	0.000118	0.000245	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP1B1—melanoma	0.000118	0.000245	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP17A1—melanoma	0.000116	0.000242	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CG—melanoma	0.000115	0.00024	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—IL6—melanoma	0.000113	0.000234	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—IL6—melanoma	0.000113	0.000234	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PPARG—melanoma	0.000111	0.000231	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNA11—melanoma	0.00011	0.000228	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—FASN—melanoma	0.000107	0.000223	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—LUM—melanoma	0.000107	0.000222	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PHGDH—melanoma	0.000107	0.000222	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLA2G6—melanoma	0.000106	0.00022	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLA2G6—melanoma	0.000106	0.00022	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC5A5—melanoma	0.000106	0.00022	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HPSE—melanoma	0.000105	0.000218	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—melanoma	0.000104	0.000216	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—melanoma	0.000104	0.000216	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CUBN—melanoma	0.000103	0.000214	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GNAQ—melanoma	0.000102	0.000212	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CD44—melanoma	0.000102	0.000212	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CD—melanoma	0.000101	0.000211	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—melanoma	0.0001	0.000208	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BSG—melanoma	9.92e-05	0.000206	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SDHD—melanoma	9.92e-05	0.000206	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CSPG4—melanoma	9.92e-05	0.000206	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP1B1—melanoma	9.78e-05	0.000203	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—melanoma	9.69e-05	0.000202	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPAM—melanoma	9.61e-05	0.0002	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—VCAN—melanoma	9.52e-05	0.000198	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—VCAN—melanoma	9.52e-05	0.000198	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	9.01e-05	0.000187	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PRKCA—melanoma	8.92e-05	0.000185	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ERCC2—melanoma	8.85e-05	0.000184	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CB—melanoma	8.84e-05	0.000184	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—melanoma	8.75e-05	0.000182	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.7e-05	0.000181	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLA2G6—melanoma	8.17e-05	0.00017	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—melanoma	8.06e-05	0.000168	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP17A1—melanoma	8.03e-05	0.000167	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP17A1—melanoma	8.03e-05	0.000167	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.92e-05	0.000165	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.82e-05	0.000163	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTEN—melanoma	7.63e-05	0.000159	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNA11—melanoma	7.58e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNA11—melanoma	7.58e-05	0.000158	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—FASN—melanoma	7.42e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—FASN—melanoma	7.42e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PRKCA—melanoma	7.41e-05	0.000154	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ERCC2—melanoma	7.35e-05	0.000153	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—VCAN—melanoma	7.34e-05	0.000153	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC5A5—melanoma	7.3e-05	0.000152	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC5A5—melanoma	7.3e-05	0.000152	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GNAQ—melanoma	7.05e-05	0.000147	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CD44—melanoma	7.05e-05	0.000147	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CD44—melanoma	7.05e-05	0.000147	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GNAQ—melanoma	7.05e-05	0.000147	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CG—melanoma	6.99e-05	0.000145	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.9e-05	0.000144	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.84e-05	0.000142	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP1B1—melanoma	6.76e-05	0.000141	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP1B1—melanoma	6.76e-05	0.000141	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PPARG—melanoma	6.74e-05	0.00014	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP17A1—melanoma	6.19e-05	0.000129	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CD—melanoma	6.14e-05	0.000128	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—melanoma	6.06e-05	0.000126	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.97e-05	0.000124	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNA11—melanoma	5.85e-05	0.000122	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CG—melanoma	5.81e-05	0.000121	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FASN—melanoma	5.72e-05	0.000119	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC5A5—melanoma	5.63e-05	0.000117	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PPARG—melanoma	5.6e-05	0.000117	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—melanoma	5.57e-05	0.000116	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—melanoma	5.57e-05	0.000116	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GNAQ—melanoma	5.43e-05	0.000113	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CD44—melanoma	5.43e-05	0.000113	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PIK3CA—melanoma	5.39e-05	0.000112	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CB—melanoma	5.35e-05	0.000111	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—melanoma	5.3e-05	0.00011	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP1B1—melanoma	5.21e-05	0.000108	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PRKCA—melanoma	5.12e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PRKCA—melanoma	5.12e-05	0.000107	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CD—melanoma	5.1e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ERCC2—melanoma	5.08e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ERCC2—melanoma	5.08e-05	0.000106	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—melanoma	5.04e-05	0.000105	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTEN—melanoma	4.63e-05	9.62e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CB—melanoma	4.45e-05	9.25e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—melanoma	4.41e-05	9.17e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—melanoma	4.4e-05	9.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—melanoma	4.29e-05	8.92e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.21e-05	8.75e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CG—melanoma	4.01e-05	8.34e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CG—melanoma	4.01e-05	8.34e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PRKCA—melanoma	3.95e-05	8.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ERCC2—melanoma	3.92e-05	8.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPARG—melanoma	3.87e-05	8.05e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPARG—melanoma	3.87e-05	8.05e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTEN—melanoma	3.85e-05	8e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CD—melanoma	3.53e-05	7.34e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CD—melanoma	3.53e-05	7.34e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—melanoma	3.48e-05	7.24e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—melanoma	3.48e-05	7.24e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PIK3CA—melanoma	3.26e-05	6.79e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CG—melanoma	3.09e-05	6.43e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CB—melanoma	3.07e-05	6.39e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CB—melanoma	3.07e-05	6.39e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—melanoma	3.05e-05	6.34e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—melanoma	3.05e-05	6.34e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPARG—melanoma	2.99e-05	6.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CD—melanoma	2.72e-05	5.66e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PIK3CA—melanoma	2.71e-05	5.64e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—melanoma	2.68e-05	5.58e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—melanoma	2.67e-05	5.54e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTEN—melanoma	2.66e-05	5.53e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTEN—melanoma	2.66e-05	5.53e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CB—melanoma	2.37e-05	4.93e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—melanoma	2.35e-05	4.88e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—melanoma	2.22e-05	4.61e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTEN—melanoma	2.05e-05	4.26e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PIK3CA—melanoma	1.87e-05	3.9e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PIK3CA—melanoma	1.87e-05	3.9e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—melanoma	1.53e-05	3.18e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—melanoma	1.53e-05	3.18e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PIK3CA—melanoma	1.44e-05	3e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—melanoma	1.18e-05	2.45e-05	CbGpPWpGaD
